chr4-69754755-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_014465.4(SULT1B1):āc.192T>Cā(p.Asp64=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00585 in 1,612,832 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0041 ( 0 hom., cov: 33)
Exomes š: 0.0060 ( 44 hom. )
Consequence
SULT1B1
NM_014465.4 synonymous
NM_014465.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.397
Genes affected
SULT1B1 (HGNC:17845): (sulfotransferase family 1B member 1) Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. However, the total genomic length of this gene is greater than that of other SULT1 genes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 4-69754755-A-G is Benign according to our data. Variant chr4-69754755-A-G is described in ClinVar as [Benign]. Clinvar id is 787615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.397 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 44 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SULT1B1 | NM_014465.4 | c.192T>C | p.Asp64= | synonymous_variant | 3/8 | ENST00000310613.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SULT1B1 | ENST00000310613.8 | c.192T>C | p.Asp64= | synonymous_variant | 3/8 | 1 | NM_014465.4 | P1 | |
SULT1B1 | ENST00000510821.1 | c.192T>C | p.Asp64= | synonymous_variant | 4/6 | 3 | |||
SULT1B1 | ENST00000512870.1 | c.135T>C | p.Asp45= | synonymous_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00413 AC: 628AN: 152152Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
628
AN:
152152
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00432 AC: 1083AN: 250580Hom.: 7 AF XY: 0.00455 AC XY: 616AN XY: 135432
GnomAD3 exomes
AF:
AC:
1083
AN:
250580
Hom.:
AF XY:
AC XY:
616
AN XY:
135432
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00603 AC: 8803AN: 1460562Hom.: 44 Cov.: 30 AF XY: 0.00596 AC XY: 4333AN XY: 726594
GnomAD4 exome
AF:
AC:
8803
AN:
1460562
Hom.:
Cov.:
30
AF XY:
AC XY:
4333
AN XY:
726594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00412 AC: 627AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.00367 AC XY: 273AN XY: 74462
GnomAD4 genome
AF:
AC:
627
AN:
152270
Hom.:
Cov.:
33
AF XY:
AC XY:
273
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at